Suspected Cancer: recognition and referral (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 27 March 2026
Tisotumab vedotin for treating recurrent or metastatic cervical cancer after chemotherapy [ID3753]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 25 June 2026